Conceivable Life Sciences, which is building an automated in vitro fertilization (IVF) laboratory, raised a $50 million Series A, CEO Alan Murray tells Axios Pro.
Why it matters: The financing helps Conceivable expand partnerships with fertility networks and launch in the U.S. next year.
